Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
Journal of Alzheimer'S Disease : JAD
|
October 9, 2010
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease
Davide Chiasserini, Lucilla Parnetti, Ulf Andreasson, et al.
Cancers
|
November 13, 2021
A Prostate Cancer Proteomics Database for SWATH-MS Based Protein Quantification
Ammara Muazzam, Davide Chiasserini, Janet Kelsall, et al.
Haematologica
|
October 11, 2015
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia
Loredana Bury, Emanuela Falcinelli, Davide Chiasserini, et al.
Nature Communications
|
January 3, 2025
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers
Anna L Wojdała, Giovanni Bellomo, Lorenzo Gaetani, et al.
Neurobiology of Disease
|
December 24, 2025
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease
Giovanni Bellomo, Andrea Toja, Lorenzo Gaetani, et al.
Nature Reviews. Neurology
|
February 20, 2013
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti, Anna Castrioto, Davide Chiasserini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 8, 2017
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis
Paolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
Molecular Neurodegeneration
|
September 9, 2016
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF
Claudia Cicognola, Davide Chiasserini, Paolo Eusebi, et al.
Journal of Alzheimer'S Disease : JAD
|
July 5, 2022
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation
Anna Lidia Wojdała, Davide Chiasserini, Giovanni Bellomo, et al.
BMJ Open
|
June 15, 2016
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis
Paolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
Journal of Alzheimer'S Disease : JAD
|
October 9, 2010
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease
Davide Chiasserini, Lucilla Parnetti, Ulf Andreasson, et al.
Cancers
|
November 13, 2021
A Prostate Cancer Proteomics Database for SWATH-MS Based Protein Quantification
Ammara Muazzam, Davide Chiasserini, Janet Kelsall, et al.
Haematologica
|
October 11, 2015
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia
Loredana Bury, Emanuela Falcinelli, Davide Chiasserini, et al.
Nature Communications
|
January 3, 2025
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers
Anna L Wojdała, Giovanni Bellomo, Lorenzo Gaetani, et al.
Neurobiology of Disease
|
December 24, 2025
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease
Giovanni Bellomo, Andrea Toja, Lorenzo Gaetani, et al.
Nature Reviews. Neurology
|
February 20, 2013
Cerebrospinal fluid biomarkers in Parkinson disease
Lucilla Parnetti, Anna Castrioto, Davide Chiasserini, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 8, 2017
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis
Paolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
Molecular Neurodegeneration
|
September 9, 2016
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF
Claudia Cicognola, Davide Chiasserini, Paolo Eusebi, et al.
Journal of Alzheimer'S Disease : JAD
|
July 5, 2022
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation
Anna Lidia Wojdała, Davide Chiasserini, Giovanni Bellomo, et al.
BMJ Open
|
June 15, 2016
Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis
Paolo Eusebi, David Giannandrea, Leonardo Biscetti, et al.
Page
of 9